Zeus Sleep has secured a grant from the National Institute for Health and Care Research (NIHR) to fund one of the largest trials for OSA in UK history.

ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and ...

If you have been struggling with sleep apnea for a while now, then you undeniably understand that this sleep disorder can affect the overall quality of your day. It disrupts... The post What Is Oral ...

That’s been the question floating around ResMed's (ASX:RMD) HQ for the past five years, given its obstructive sleep apnea ...

According to the Sleep Apnea Association, “CPAP dermatitis is a type of skin irritation or rash caused by using a CPAP ...

Tirzepatide significantly improved cardiometabolic risk markers in adults with obesity and moderate to severe obstructive ...

Obstructive sleep apnea, a breathing disorder where the airway becomes blocked during sleep, comes with numerous health risks ...

Even though many CGM users still need test strips for calibration or backup, insurers are cutting quantities dramatically.

REMSleep says the final pieces of its commercial strategy for the DeltaWave nasal pillow system are falling into place as the company prepares for a broader market push.

It’s estimated eight million people in the UK have sleep apnoea, which causes breathing to repeatedly stop and start ...

ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...

Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion ...